Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
11/2008
11/19/2008CN101305826A Sparassis crsipa beverage
11/19/2008CN100434521C Structure and application of antisense oligonucleotide with gene of mid-range factor as target
11/19/2008CN100434439C Genes and polypeptides relating to chronic myeloid leukemia
11/19/2008CN100434428C Furazanobenzimidazoles
11/19/2008CN100434426C Chinese sumac lactone A , preparation method and its use in pharmacy
11/19/2008CN100434425C 4-quinazolone derivative and its use in anti-tumor medicine
11/19/2008CN100434419C Compound of monocyclic polysubstitution saturated cyclohexanones, prepartion method and usage
11/19/2008CN100434120C Amphipathic fluorescence target nano micelle and its preparation method
11/19/2008CN100434089C Use of centipeda volatile oil in preparation of tumor growth and proliferation inhibitor
11/19/2008CN100434088C Intravenous administration preparation extracted from marsdenia tenacissima stem
11/19/2008CN100434085C Process for removing toxic component from oleum fructus bruceae
11/19/2008CN100434077C Megestrol acetate capsule composition
11/19/2008CN100434068C Bexarotene gel and its preparation method
11/19/2008CN100434066C Curcuma longa extract injection, and preparing process and use thereof
11/18/2008US7453011 Cycloalkyl substituted polyamines for cancer therapy and methods of synthesis therefor
11/18/2008US7452977 Antibody to a kinase capable of site-specific phosphorylation of IκBα
11/18/2008US7452976 Immunoglobulin specific to kinase insert domain-containing receptor (KDR) for use in treatment and prevention of inflammation, psoriasis, rheumatoid arthritis and tumor growth; immunotherapy
11/18/2008US7452913 Patterns of enzyme inhibitors formed by dissolving compounds and isolation by precipitation
11/18/2008US7452912 Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by VLA-4
11/18/2008US7452910 Reducing side effects, lowering neurotoxicity; longer lasting antitumor action
11/18/2008US7452907 Conformationally constrained analogs useful as antidiabetic and antiobesity agents and method
11/18/2008US7452906 For therapy of neurotraumatic diseases, cancer, chronic neurodegeneration, pain, migraine and cardiac hypertrophy
11/18/2008US7452902 Imidazopyridines as cyclin dependent kinase inhibitors
11/18/2008US7452900 Esters in position 20 of camptothecins
11/18/2008US7452898 Use of 1-O-octadecylpropanediol-3-cidofovir to treat viral diseases such as HIV, influenza, herpes virus, cytomegalovirus, hepatitis virus, Epstein-Barr virus, varicella zoster virus, orthopox virus, ebola virus and papilloma virus
11/18/2008US7452886 E.g., 6-(6-Chloro-pyridin-3-yloxymethyl)-7-(2,2-dimethyl-propyl)-7H-pyrrolo[2,3-d]pyrimidine-2-carbonitrile; in particular, cathepsin K inhibitors; osteoporosis; oral, autoimmune and respiratory diseases; osteoarthritis; antiarthritic and antitumor agents; muscular dystrophy; amytrophy; parasiticides
11/18/2008US7452884 Methods for inhibiting angiogenesis
11/18/2008US7452873 Inhibitors of GSK-3 and uses thereof
11/18/2008US7452859 Having serine protease inhibitory activity
11/18/2008US7452723 Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders
11/18/2008US7452717 Carboxylesterase; antitumor agents; drug screening; bioassay
11/18/2008US7452551 Administering to the patient a contrast agent comprising, in an aqueous carrier, targeted vesicles formulated from a lipid or polymer, a perfluorocarbon gas, a targeting ligand, scanning the patient using ultrasound to obtain an image
11/18/2008US7452535 Methods of treatment using CTLA-4 antibodies
11/18/2008US7452534 low antigenicity, reduced (or absent) T cell depleting activity, good affinity to human CD4 and enhanced stability (in vivo half-life); chimeric antibodies contain Old World monkey variable sequences and human constant domain sequences
11/18/2008CA2588106A1 Single-domain antibodies and heavy chain antibody against egfr and uses thereof
11/18/2008CA2493704C Platinum complexes containing chemically modified bile acids, having antitumor activity
11/18/2008CA2462572C Tetracycline derivatives and methods of use thereof
11/18/2008CA2457070C A method for processing tea flower
11/18/2008CA2422379C Pyrazole compounds useful as protein kinase inhibitors
11/18/2008CA2417500C Erbb-2 selective small molecule kinase inhibitors
11/18/2008CA2416147C Dermal application system for aminolevulinic acid
11/18/2008CA2415840C Pharmaceutical pellets comprising tamsulosin and a process for making the same
11/18/2008CA2395481C Hormone receptor modulation
11/18/2008CA2383630C Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
11/18/2008CA2362281C Combinations for the treatment of diseases involving angiogenesis
11/18/2008CA2336945C Treatment regimen for administration of phenylacetylglutamine, phenylacetylisoglutamine, and/or phenylacetate
11/18/2008CA2334146C Radioiodinated phenols for brachytherapy
11/18/2008CA2293706C N-substituted urea inhibitors of farnesyl-protein transferase
11/18/2008CA2265444C Tnf-beta-like protein for treating prostate cancer, and related nucleic acid molecules, pharmaceutical compositions and methods
11/18/2008CA2247115C Inhibition of selectin binding
11/18/2008CA2186851C Use of mycobacteria for the treatment of tumours
11/18/2008CA2133587C Compounds having selectivity for retinoid x receptors
11/18/2008CA2124329C Compounds, compositions and methods for binding bio-affecting substances to surface membranes of bio-particles
11/18/2008CA1341585C Recombinant retroviruses
11/13/2008WO2008137930A1 TNFα GENE EXPRESSION AS A BIOMARKER OF SENSITIVITY TO ANTAGONISTS OF INHIBITOR OF APOPTOSIS PROTEINS
11/13/2008WO2008137794A1 Compounds and compositions as c-kit and pdgfr kinase inhibitors
11/13/2008WO2008137770A1 Compounds and compositions as c-kit and pdgfr kinase inhibitors
11/13/2008WO2008137740A1 Fulvene and fulvalene analogs and their use in treating cancers
11/13/2008WO2008137622A2 Aminopyrimidines useful as kinase inhibitors
11/13/2008WO2008137621A1 Aminopyrimidines useful as kinase inhibitors
11/13/2008WO2008137605A1 Pyrimidine derivatives and compositions as c-kit and pdgfr kinase inhibitors
11/13/2008WO2008137420A1 Honokiol analogs and their use in treating cancers
11/13/2008WO2008137060A1 Thienopyridine and thiazolopyridine derivatives that inhibit prolyl hydroxylase activity
11/13/2008WO2008136976A2 Compounds for treating proliferative disorders
11/13/2008WO2008136850A2 Cobalamin conjugates useful as imaging and therapeutic agents
11/13/2008WO2008136848A2 Novel anti-notch3 antibodies and their use in the detection and diagnosis of disease
11/13/2008WO2008136838A1 Novel amide derivatives of cddo and methods of use thereof
11/13/2008WO2008136774A1 Antibodies binding to an intracellular prl-1 or prl-3 polypeptide
11/13/2008WO2008136748A1 Tumour growth inhibitory compounds and methods of their use
11/13/2008WO2008136736A2 Immunoregulatory structures from normally occurring proteins
11/13/2008WO2008136705A2 Drugs for treating and preventing benign prostatic hyperplasia, prostatitis, impotency, infertility and prostate cancer and a method for the use thereof
11/13/2008WO2008136541A1 Angiogenesis inhibitor comprising meteorin as an active ingredient
11/13/2008WO2008136519A1 Cytotoxic t cell activator comprising ep4 agonist
11/13/2008WO2008136438A1 Viral vector for gene therapy
11/13/2008WO2008136382A1 Bicyclic compound and pharmaceutical use thereof
11/13/2008WO2008136213A1 Radiosensitivity-enhancing agent
11/13/2008WO2008136018A2 4beta-amin0 podophyllotoxin congeners as potential anticancer agents and a process for the preparation thereof
11/13/2008WO2008135993A1 Klotho protein and related compounds for the treatment and diagnosis of cancer
11/13/2008WO2008135984A1 Composition comprising s-allylmercapto-n-acetylcysteine (assnac) for up-regulation of cellular glutathione level
11/13/2008WO2008135886A2 Quinoline derivatives for use in the inhibition of the growth of tumour cells
11/13/2008WO2008135793A1 Combination of aplidine and carboplatin in anticancer treatments
11/13/2008WO2008135792A1 Pm00104 compound for use in cancer therapy
11/13/2008WO2008135786A1 Amino-thiazolyl- pyrimidine derivatives and their use for the treatment of cancer
11/13/2008WO2008135785A1 9- (pyrazol- 3 -yl) - 9h- purine-2 -amine and 3- (pyraz0l-3-yl) -3h-imidaz0 [4, 5-b] pyridin-5-amine derivatives and their use for the treatment of cancer
11/13/2008WO2008135232A1 Use and compositions of purine derivatives for the treatment of proliferative disorders
11/13/2008WO2008135153A1 Novel polymorphic form of 2-(4-fluorophenyl)-4-3-hydroxy-3-methyl-1-butoxy)-5-[4-methyl-sulfonyl)phenyl]-3(2h)-pyridazinone (fhmp)
11/13/2008WO2008135152A1 Novel amorphous forms of 2-(4-fluorophenyl)-4-3-hydroxy-3-methyl-1-butoxy)-5-[4-methyl-sulfonyl)phenyl]-3(2h)-pyridazinone (fhmp)
11/13/2008WO2008134935A1 Truncated human papillomavirus type 18 l1 proteins
11/13/2008WO2008134934A1 A truncated l1 protein of human papillomavirus 16
11/13/2008WO2008134919A1 Ejaculum of animals as medicinal material and uses thereof in medicaments for treatment of diseases such as tumors, depression, etc.
11/13/2008WO2008134879A1 Il-12 immunotherapy for cancer
11/13/2008WO2008134878A1 Compositions and methods for cancer treatment
11/13/2008WO2008134876A1 Cancerous disease modifying antibodies
11/13/2008WO2008121941B1 Prodrugs of triciribine and triciribine phosphate
11/13/2008WO2008118454A3 Derivatives of quinoline or benzopyrazine and their uses for the treatment of (inter alia) inflammatory diseases, autoimmune diseases or various kinds of cancer
11/13/2008WO2008115369A3 Inhibitors of focal adhesion kinase
11/13/2008WO2008114275A3 Anthranilic acid derivatives as anticancer agents and process for the preparation thereof
11/13/2008WO2008113469A3 Substituted imidazopyrimidines and triazolopyrimidines
11/13/2008WO2008112192A3 Epha3 antibodies for the treatment of solid tumors
11/13/2008WO2008109493A3 Nucleic acid compounds for inhibiting cd19 gene expression and uses thereof
1 ... 892 893 894 895 896 897 898 899 900 901 902 903 904 905 906 907 908 909 910 911 912 ... 2211